CHAPTER 961
UNIFORM CONTROLLED SUBSTANCES ACT
961.001 Declaration of intent.
961.003 Uniformity of interpretation.
SUBCHAPTER I
DEFINITIONS
SUBCHAPTER II
STANDARDS AND SCHEDULES
961.11 Authority to control.
961.115 Native American Church exemption.
961.15 Schedule II tests.
961.17 Schedule III tests.
961.19 Schedule IV tests.
961.23 Dispensing of schedule V substances.
961.235 Records relating to sales of pseudoephedrine products.
961.24 Publishing of updated schedules.
961.25 Controlled substance analog treated as a schedule I substance.
SUBCHAPTER III
REGULATION OF MANUFACTURE, DISTRIBUTION AND DISPENSING OF CONTROLLED SUBSTANCES
961.32 Possession authorization.
961.335 Special use authorization.
961.337 Drug disposal programs.
961.34 Controlled substances therapeutic research.
961.36 Controlled substances board duties relating to diversion control and prevention, compliance with controlled substances law and advice and assistance.
961.39 Limitations on optometrists.
961.395 Limitation on advanced practice nurses.
SUBCHAPTER IV
OFFENSES AND PENALTIES
961.41 Prohibited acts A — penalties.
961.42 Prohibited acts B — penalties.
961.43 Prohibited acts C — penalties.
961.435 Specific penalty.
961.44 Penalties under other laws.
961.443 Immunity from criminal prosecution; possession.
961.45 Bar to prosecution.
961.452 Defenses in certain schedule V prosecutions.
961.453 Purchases of pseudoephedrine products on behalf of another person.
961.455 Using a child for illegal drug distribution or manufacturing purposes.
961.46 Distribution to persons under age 18.
961.47 Conditional discharge for possession or attempted possession as first offense.
961.472 Assessment; certain possession or attempted possession offenses.
961.475 Treatment option.
961.48 Second or subsequent offenses.
961.49 Offenses involving intent to deliver or distribute a controlled substance on or near certain places.
961.495 Possession or attempted possession of a controlled substance on or near certain places.
961.50 Suspension or revocation of operating privilege.
SUBCHAPTER V